Overview of pregnancy in solid-organ transplantation

Curr Opin Organ Transplant. 2023 Aug 1;28(4):271-278. doi: 10.1097/MOT.0000000000001075. Epub 2023 May 23.

Abstract

Purpose of review: Pregnancy in solid organ transplantation (SOT) is a very complex part of transplant medicine wherein there is scarce information available in the literature. Solid organ transplant recipients often have comorbidities, such as hypertension and diabetes, which add additional risk to a pregnancy.

Recent findings: We present this review article on the various aspects of different types of immunosuppressant medications used in pregnancy with added inputs on contraception and fertility after transplant. We described the antepartum and postpartum considerations and discussed the adverse effects of the immunosuppressive medications. Maternal and fetal complications of each SOT have been also discussed in this article.

Summary: This article will serve as the primary review articles for the use of immunosuppressive medications during pregnancy with consideration during pregnancy after SOT.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Organ Transplantation* / adverse effects
  • Pregnancy
  • Transplant Recipients
  • Transplants*

Substances

  • Immunosuppressive Agents